NABI BIOPHARMACEUTICALS 4
4 · NABI BIOPHARMACEUTICALS · Filed Nov 6, 2003
Insider Transaction Report
Form 4
GURY DAVID J
Director
Transactions
- Sale
Common Stock
2003-11-04$11.16/sh−4,000$44,640→ 552,158.581 total - Sale
Common Stock
2003-11-05$11.25/sh−4,000$45,000→ 113,400 total(indirect: By immediate family)
Holdings
- 1,500(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.